Stress and strain on the U.S. drug supply: The intersection of shortages, globalization, counterfeit products, and throw in a global COVID-19 pandemic

J Am Pharm Assoc (2003). 2021 Jan-Feb;61(1):e85-e86. doi: 10.1016/j.japh.2020.11.015.
No abstract available

Publication types

  • Editorial

MeSH terms

  • COVID-19*
  • Counterfeit Drugs / supply & distribution*
  • Humans
  • Internationality
  • Pharmaceutical Preparations / standards
  • Pharmaceutical Preparations / supply & distribution*
  • United States

Substances

  • Counterfeit Drugs
  • Pharmaceutical Preparations